Tidal Investments LLC Acquires 103,489 Shares of SPDR S&P Biotech ETF $XBI

Tidal Investments LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1,771.5% during the second quarter, HoldingsChannel reports. The fund owned 109,331 shares of the exchange traded fund’s stock after acquiring an additional 103,489 shares during the quarter. Tidal Investments LLC’s holdings in SPDR S&P Biotech ETF were worth $17,302,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of XBI. Bank of America Corp DE lifted its stake in SPDR S&P Biotech ETF by 13.3% during the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after purchasing an additional 1,700,851 shares during the period. Morgan Stanley grew its holdings in shares of SPDR S&P Biotech ETF by 8.3% during the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after purchasing an additional 882,718 shares during the last quarter. Wells Fargo & Company MN increased its position in SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after acquiring an additional 1,536,122 shares in the last quarter. Avoro Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $256,053,000. Finally, Bessemer Group Inc. increased its stake in shares of SPDR S&P Biotech ETF by 13.5% in the 4th quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock valued at $225,965,000 after buying an additional 220,244 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI opened at $156.82 on Friday. The company has a market cap of $10.24 billion, a price-to-earnings ratio of 11.47 and a beta of 0.84. SPDR S&P Biotech ETF has a fifty-two week low of $92.64 and a fifty-two week high of $169.89. The firm has a 50 day simple moving average of $158.35 and a 200 day simple moving average of $141.62.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.